TrialBMC medicine2024

Safety, tolerability, pharmacokinetics, and pharmacodynamics of TG103 injection in participants who are overweight or obese: a randomized, double-blind, placebo-controlled, multiple-dose phase 1b study.

Diaozhu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.